Navigation Links
10-Week "Biotech Entrepreneur Educational Program" Enrolling in New York City
Date:12/11/2012

NEW YORK, Dec. 11, 2012 /PRNewswire/ -- Kauffman FastTrac® in conjunction with Propero/Healthcare Accelerator (Propero/HCA) announces the launch of FastTrac® LifeSciences™, a 10-week professional business course designed specifically for aspiring entrepreneurs who either have an idea for a science business or have already started a business and need a plan to successfully grow.

Instructed by Laurence "Larry" Chaityn, founder of Propero/HCA and Global Head Healthcare Investment Banking at Kaminski Partners, the FastTrac LifeSciences course will provide participants a forum to:

  • Test their business' product/service, patient base, financial plan and technological viability
  • Find the target market for their business and discover its competitive advantage
  • Learn how to value their business and raise money from funding sources
  • Determine the stages to profitability
  • Learn successful regulatory strategies, including correct protocol, achievable endpoints and correct patient participants
  • Understand reimbursement strategies including differing reimbursement environments, multiple codes, limited reimbursement and attended monitoring

FastTrac LifeSciences will be held at Loeb & Loeb, 345 Park Avenue, 21st floor Conference Center. Classes begin Monday, January 28, 2013 at 5:30 p.m. EST and will be held each successive Monday for 10 weeks.  Space is limited. Participants can register at http://properohca.affiliate.fasttrac.org/.

"Interesting science and a novel mechanism of action are important when launching a biotechnology company, but success hinges on a multitude of factors, many of which occur in the boardroom and not at the bench," Chaityn said. "I look forward to helping life sciences entrepreneurs develop the essential business strategies that will allow them to navigate the hurdles of today's regulatory and financial landscape."

About Laurence Chaityn:
Laurence "Larry" Chaityn is the founder of Propero/HCA and Managing Director and Global Head Healthcare Investment Banking at Kaminski Partners.  With more than 12 years of healthcare and life science consulting experience, he has built expertise in deal sourcing, deal review, due diligence investigation and client facing operations. Chaityn has worked with executive and senior management at Johnson & Johnson, Pfizer, Bayer Pharmaceuticals, Merck, Bristol Meyers Squibb (BMS) and others.

About Propero/Healthcare Accelerator:
ProperoHCA's mandate is to grow Healthcare/Life Science companies. One of the key assets is the network of nationwide hospital CEOs, CFOs & CAOs. This relationship, coupled with our knowledge of the healthcare landscape enables us to map specific hospital challenges and business initiatives for our clients. The overarching goal is to create a scalable sales organization that minimizes the cost of customer acquisition, streamlines the overall sales cycle and maximizes the revenue yield per employee.

Media Contact:
Tiberend Strategic Advisors, Inc.
Claire Sojda
212-827-0020
csojda@tiberend.com


'/>"/>
SOURCE Kauffman FastTrac
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Dr. Alice Jacobs, CEO of IntelligentMDx, Named Best Entrepreneur in Eighth Annual Stevie® Awards for Women in Business
2. Minority Biomedical Entrepreneurship Conference
3. Entrepreneurs to Eat Problems for Breakfast in San Diego
4. Leading Technology Incubator Honors Extraordinary Entrepreneurs
5. invivodata President Selected as Finalist for Ernst & Young Entrepreneur of the Year Award
6. Western Carolina University, College of Business Appoints New Director of Entrepreneurship and Innovation
7. Rosetta Genomics Receives 2012 North American Entrepreneurial Company of the Year Award by Frost & Sullivan
8. Hawaii Tech Asia Takes Hawaii & US Entrepreneurs To China
9. Novo Nordisk To Award $80,000 To Local Programs That Help People Living With Diabetes In Detroit As Part Of Educational Initiative
10. Texas Medical Center, the largest concentration of medical research, educational and healthcare organizations in the world, announces the first Houston Stem Cell Summit to highlight the latest stem cell research and commercialization efforts
11. NIRI San Diego May Meeting: Seasoned IROs Discuss "Tips & Tactics for Establishing and Maintaining A Successful Investor Relations Program"
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/31/2016)... 31, 2016 BioRap Technologies Ltd ... Biomedical Research at the Technion - Israel Institute of Technology, ... with Pfizer Inc. (NYSE: PFE ) that aims ... treatment options for a number of chronic autoimmune diseases. ... by Prof. Nathan Karin and his research team, ...
(Date:5/31/2016)... MB (PRWEB) , ... May 31, 2016 , ... ... develops and markets molecular imaging systems, today announced that their compact PET scanner ... (Magnetic Resonance Imaging) has been selected by the University of Arizona (UA). , ...
(Date:5/27/2016)... , ... May 27, 2016 , ... Weeks after hosting ... in Phoenix, Dr. Michael Fitzmaurice, hand surgeon and founder of the Fitzmaurice Hand Institute, ... The Wrist MRI machine is a state-of-the-art technology and only 1 of about 3 ...
(Date:5/27/2016)... Jersey and READING, ... -- Indegene ( http://www.indegene.com ), ... marketingorientierten Lösungen für die Life-Science-Branche, Pharmaunternehmen und ... bekannter weltweiter Anbieter von innovativen wissenschaftlichen Support-Services ... des Starts von IntraScience heute den Ausbau ...
Breaking Biology Technology:
(Date:4/15/2016)... 2016 Research and Markets has ... Market 2016-2020,"  report to their offering.  , ... ,The global gait biometrics market is expected to ... period 2016-2020. Gait analysis generates multiple ... used to compute factors that are not or ...
(Date:4/13/2016)...  IMPOWER physicians supporting Medicaid patients in ... standard in telehealth thanks to a new partnership with ... IMPOWER patients can routinely track key health measurements, such ... and, when they opt in, share them with IMPOWER ... local retail location at no cost. By leveraging this ...
(Date:3/31/2016)... 2016  Genomics firm Nabsys has completed a financial ... Bready , M.D., who returned to the company in ... leadership team, including Chief Technology Officer, John Oliver ... Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys from ...
Breaking Biology News(10 mins):